Background. Presenting systolic blood pressure (SBP) is a powerful predictor of mortality in many cardiovascular settings, including acute coronary syndromes, cardiogenic shock and acute heart failure. Objectives. This study evaluated the association of presenting SBP with in-hospital outcomes, specifically all-cause mortality, in acute aortic dissection (AAD). Methods. The study included 6238 consecutive patients (4167 with type A and 2071 with type B AAD) enrolled in the International Registry of Acute Aortic Dissection. Patients were stratified in four groups according to presenting SBP: SBP>150 mmHg, SBP 101-150 mmHg, SBP 81-100 mmHg or SBP80 mmHg. Results. The relationship between presenting SBP and in-hospital mortality displayed a J-curve association, with significantly higher mortality rates in patients with very high SBP (26.3% for SBP>180 mmHg in type A AAD, 13.3% for SBP>200 mmHg in type B AAD; p=0.005 and p=0.018 respectively) as well as in those with SBP100 mmHg (29.9% in type A, 22.4% in type B; p=0.033 and p=0.015 respectively). This relationship was mainly due to increased rates of inhospital complications (acute renal failure, coma and mesenteric ischemia/infarction in patients with SBP>150 mmHg; stroke, coma, cardiac tamponade and acute renal failure in patients with SBP80 mmHg). Notably, presenting SBP80 mmHg was independently associated with inhospital mortality in both type A (p=0.001) and type B AAD (p=0.003). Conclusions. Presenting SBP showed a clear J-curve relationship with in-hospital mortality in AAD patients. Although this association was related to increased rates of comorbid conditions at the edges of the curve, SBP80 mmHg was an independent correlate of in-hospital mortality.
Introduction
Blood pressure has been shown to be a key determinant of adverse events in patients with cardiovascular disease (1) . A J-shaped association has been demonstrated between serial blood pressure levels and cardiovascular events as well as all-cause mortality (2) (3) (4) . Additionally, presenting systolic blood pressure (SBP) is a powerful predictor of mortality in the setting of acute cardiovascular conditions including acute coronary syndromes, cardiogenic shock and acute heart failure, and is incorporated in several well-validated risk prediction algorithms, such as the Global Registry of Acute Coronary Events (GRACE) score (5, 6) . However, the association of SBP at presentation with in-hospital outcomes in patients with acute aortic dissection (AAD) is unknown.
Aim of the present study was to evaluate the association of presenting SBP levels with inhospital outcomes, specifically all-cause mortality, among unselected consecutive type A and type B AAD patients.
Methods

Study Population
This study included patients with type A and B AAD enrolled in the International Registry of Acute Aortic Dissection (IRAD) between 1996 and 2016 with available SBP values at presentation. The structure and methods of IRAD have been previously published (7, 8) .
Patients were identified prospectively at presentation and/or retrospectively via discharge diagnoses, imaging, and hospital databases. Diagnosis was confirmed by imaging, surgical visualization, or autopsy. Each site's institutional review committee approved participation in IRAD. Patients were stratified by presenting SBP levels in four groups based on the categories defined on the IRAD form: SBP >150 mmHg, SBP 101-150 mmHg, SBP 81-100 mmHg or SBP 80 mmHg (9) .
A total of 7333 patients with AAD were enrolled in IRAD. Of these, 387 were excluded due to the presence of intramural hematoma versus AAD, 708 were excluded due to missing data on SBP. The remaining 6238 patients (4167 type A AAD and 2071 type B AAD) were included in the study population.
Data collection and definitions
Data on 290 variables were recorded on a standardized form that included patient demographics, history, clinical presentation, imaging results, treatment, and outcomes. Data were reviewed for internal consistency and validity and entered into an online database. Type A and B AAD were defined as any non-traumatic dissection of the aorta respectively proximal and distal to the left subclavian artery, presenting within 14 days from symptom onset (10).
Statistical Analysis
Data are shown as frequencies and percentages for categorical variables and as mean ± standard deviation, or medians with 1st and 3rd quartiles. The Kruskal-Wallis test was used for data with skewed distributions. Analysis of variance for multiple groups was used to compare normally distributed continuous variables. Multiple Chi-square test was used to compare categorical data. If significant differences were found between multiple groups, post-hoc pairwise analysis utilizing the Student's T-test or the Mann-Whitney U test was used to determine which categories displayed significance. In all cases, missing data were not defaulted to negative and denominators reflect cases for which information was reported and available.
Risk adjustment was performed to determine the association of presenting SBP with in-hospital mortality using multivariable logistic regression model using a backward stepwise method, introducing variables with p<0.15 on univariate analysis. Odd ratios and 95% confidence intervals were provided to demonstrate the strength of association. All p-values were two-sided with values <0.05 considered statistically significant. Analyses were performed using SPSS 22.0 statistical analysis software (IBM Corporation).
Results
Type A: Clinical features at presentation
Baseline characteristics of type A AAD patients are reported in Table 1 . The majority of patients had normal or borderline hypertensive SBP (101-150 mmHg [41.4%]) at the initial presentation, followed by patients with SBP >150 mmHg (27.4%) and with SBP 81-100 mmHg or SBP 80 mmHg (respectively 15.3% and 15.9%). Patients with SBP 80 mmHg were older (p<0.001), and more often smokers (p=0.013), with medical history of peripheral artery disease (p<0.001). As for the clinical presentation, aortic regurgitation (p=0.002), syncope (p<0.001), pulse deficits (p=0.001), stroke (p<0001), coma/altered consciousness (p<0.001), cardiac tamponade (p<0.001), congestive heart failure (p<0.001), arch vessel involvement (p=0.029) and periaortic hematoma (p<0.001) were more frequent in the SBP 80 mmHg group, as compared to the other groups. On the other hand, patients presenting with SBP >150 mmHg were more likely to have prior known diagnosis of hypertension (p<0.001), were smokers (p=0.013) and presented more frequently with back pain and abdominal pain compared to others (p<0.001 and p=0.003 respectively). Abdominal vessel involvement by the dissection flap was more common in this group, as well (p<0.001).
Management and in-hospital outcome
An urgent surgical approach was the most frequent treatment among the various groups, especially in the SBP ≤80 mmHg group (89.1%; p=0.048); however, patients with SBP >150 mmHg were more likely to receive endovascular or hybrid (surgical+endovascular) approach (p=0.022 and p=0.009 respectively). Among in-hospital complications, stroke (p=0.002), coma (p<0.001), and cardiac tamponade (p<0.001) were registered more frequently in patients with a presenting SBP 80 mmHg, whereas patients with SBP >150 mmHg showed higher rates of mesenteric ischemia/infarction (p=0.017). Acute renal failure showed comparably high rates both in patients with SBP >150 mmHg and with SBP 80 mmHg, as compared to patients with SBP 81-100 mmHg and SBP 101-150 mmHg (p=0.004). In-hospital mortality was significantly higher in patients with SBP 80 mmHg compared to all other groups (p<0.001). For patients with SBP >150 mmHg, mortality was higher compared to those with SBP 101-150 mmHg.
The relationship between SBP and in-hospital mortality is shown in the Central Illustration. After additional stratification by SBP, mortality was significantly higher for SBP 
Type B: Clinical features at presentation
At admission, the majority of type B AAD patients had SBP >150 mmHg (62.0%), followed by those with SBP 101-150 mmHg (33.1%) and SBP 81-100 mmHg (2.9%). SBP 80 mmHg at presentation was rare (1.9%). Patients presenting with SBP 80 mmHg more commonly presented with syncope or coma/altered consciousness (both p<0.001), and frequently showed signs of myocardial ischemia/infarction (p<0.001), compared to those with SBP >150 mmHg and SBP 101-150 mmHg. Not surprisingly, diagnostic imaging showed higher rates of periaortic hematoma (p<0.001), and pleural effusion (p<0.001), for patients with SBP 80 mmHg compared to others. On the other hand, patients presenting with SBP >150 mmHg more frequently had a past medical history of hypertension (p<0.001), presented with back pain as predominant symptom (p<0.001), and showed higher rates of abdominal vessel involvement by dissection flap on imaging (p=0.003) ( Table 4) .
Management, in-hospital, and long-term outcome
Data on management and in-hospital outcome are reported in Table 5 . Medical management was overall the most frequent therapeutic approach in patients with SBP >150 mmHg, whereas the surgical approach was adopted more frequently in the SBP 80 mmHg group (p<0.001). Similar to type A AAD, acute renal failure showed higher rates both in patients with SBP >150 mmHg and with SBP 80 mmHg, as compared to patients with SBP 81-100 mmHg and SBP 101-150 mmHg (p<0.001). A similar trend was evident for spinal cord ischemia (p=0.025) as well. Moreover, patients with SBP 80 mmHg had higher rates of myocardial ischemia/infarction and coma (respectively p<0.001 and p=0.001). In-hospital all-cause mortality (p<0.001) as well as mortality among the medical (p<0.001) and endovascular/hybrid treated groups (p<0.001 and p=0.006, respectively) group were higher in SBP 80 mmHg patients, as well.
The relationship between SBP and in-hospital mortality is shown in the Central Illustration. As for Type A AAD, in-hospital mortality was significantly higher (13.3%) for very high SBP values (>200 mmHg) compared to SBP 161-180 mmHg (p=0.018), improved to 6.6% for SBP values up to 120 mmHg, and was again increased for SBP 81-100 mmHg ( Table 6 ).
Discussion
To the best of authors' knowledge, this is the largest study evaluating presenting SBP levels in patients with type A and type B AAD across multiple medical centers. We observed a J shaped relationship between presenting SBP and in-hospital all-cause mortality, that showed significantly higher mortality rates in patients with very high SBP levels (>180 mmHg for type A AAD, >200 mmHg for type B) as well as in those with SBP 100 mmHg. The association of presenting SBP with mortality was related to comorbid conditions as the relationship was significantly blunted and did not remain significant for higher SBP after adjustment for differences in baseline confounders. In contrast, in both type A and type B AAD, presenting SBP 80 mmHg was found to be independently associated with in-hospital mortality when adjusting for other well established predictors of in-hospital death.
The J-curve phenomenon between blood pressure levels and cardiovascular outcomes has been observed mostly with diastolic blood pressure (11). Stewart was the first reporting a J-curve effect between diastolic blood pressure and myocardial infarction in patients receiving treatment for severe hypertension with diastolic blood pressure <90 mmHg (12) . Cruickshank et al. confirmed this finding in patients with known coronary artery disease for diastolic blood pressure levels between 85 and 90 mmHg, whereas Farnett et al. did not observe a J shaped relationship between diastolic blood pressure and stroke (13, 14) . Interestingly, recent studies reported in large cohorts of patients with coronary artery disease and hypertension or diabetes demonstrated a J-curve relationship also with SBP <130 mmHg or <120 mmHg and cardiovascular outcomes and mortality; none of these studies reported a J-curve effect for stroke (15) (16) (17) (18) . Thus, while for stroke the dictum "the lower the SBP the lower the risk" was reasonable, this was not the case for the association of myocardial infarction and cardiovascular mortality, where an excessive reduction of systolic and diastolic blood pressure may compromise myocardial perfusion, which typically occurs during diastole (19) The present study provided a unique insight into the hemodynamics of patients presenting with type A and type B AAD and showed a similar J shaped curve to that observed in the above studies, extending the paradigm of association between presenting SBP and in-hospital mortality to patients with AAD. In accordance with the above mentioned reports, hypertension was a frequent comorbid condition in patients with aortic dissection with 3 of 4 patients with AAD having this condition. Notably, patients in the SBP >150 mmHg and SBP 80 mmHg groups showed higher rates of mortality compared with those who had SBP 101-150 mmHg.
Nevertheless, the above studies and ours demonstrated that while elevated SBP at presentation may be associated with increased mortality, high SBP is a marker of increased risk for adverse events and reflects higher baseline comorbid conditions that usually account for the increased inhospital mortality. In contrast, low SBP at presentation remained an independent predictor of increased mortality even after adjustment for confounders. This is not surprising, since part of the impact of low SBP may be explained by increased comorbid conditions as in those with elevated SBP. Unlike in those with elevated SBP, hypotension may also be either a sign of myocardial dysfunction and cardiac tamponade or alternatively a reflection of significant organ compromise (i.e., myocardial ischemia, congestive heart failure, renal failure, mesenteric ischemia, cerebral hypoperfusion, etc.), which, unless reversed immediately, may itself impact mortality. To support this hypothesis, mesenteric ischemia, acute renal failure, limb ischemia and in-hospital coma were observed more frequently among patients with hypotension in our study.
Additionally, hypotension in AAD may not be easy to treat without definitive correction of AAD. In contrast, known hypertension-related complications such as aortic rupture, acute renal failure and extension of dissection flap with involvement of branch vessels are known to adversely impact in-hospital outcome of AAD (8, 21, 22) . Nonetheless, high SBP was not independently associated with adverse outcomes perhaps due to the fact that hypertension may be easier to treat medically, thereby decreasing its impact on outcomes of patient with AAD.
These hypotheses are for most part speculative and need to be confirmed in prospective studies.
Our study may have several clinical implications. Our data indicate that presenting SBP may be a marker of increased risk at presentation either related to association with increased comorbid conditions at baseline, as in the case of high baseline SBP, or as an independent correlate of in-hospital mortality over and above that predicted by baseline risk, as in the case of low SBP. This may serve as a valuable initial sign among patients with AAD that may allow physicians to more precisely arrive at risk stratification and counseling of families regarding patient's risk. Furthermore the incidence of hypotension is significantly higher among patients with AAD (30%) as compared to acute coronary syndromes (5%) (10). Thus, in hypotensive patients presenting with chest pain or back pain in the emergency room, efforts should be directed immediately for ruling out acute aortic dissection.
Limitations
The present study should be viewed in light of its limitations. First, data were collected retrospectively and/or prospectively through voluntary site participation and may be subject to bias due to incomplete, missing or inaccurate reporting of events. Secondly, sicker patients may have died before reaching the hospital, or may have not been referred to IRAD centers from community hospitals, thus altering the prevalence of patients with very low/high presenting SBP.
Similarly, the decision to treat medically or surgically was determined by the treating physician and may have influenced outcomes. Specifically, pharmacological treatment of blood pressure was not protocol driven and was determined by the treating physician in accordance with current guidelines. Our data are unable to provide insights into whether or not this factor may have had any influence on patients' outcomes. Finally, while we identified extremes of SBP at presentation as risk factors for adverse outcomes, our study is unable to provide any insights into whether correcting hyper-or hypotension can attenuate this risk, short of corrective surgery of AAD. Although physiologically plausible, further studies are needed to fully address this issue.
Conclusions
Our data indicated that presenting SBP had an important prognostic value in patients with type A and type B AAD and showed a clear J-curve relationship with in-hospital mortality.
While this association was related to increased comorbid conditions at baseline in case of those with high SBP at presentation, low SBP was an independent correlate of in-hospital mortality over and above that predicted by baseline risk. Future studies should focus on understanding whether outcomes of patients with AAD presenting with either low or high SBP could be improved by targeted treatment to normalize SBP with or without definitive corrective surgical repair.
Clinical Perspectives
Competency in Patient Care: Systolic blood pressure-either high or low-at the time of presentation with acute aortic dissection identifies patients increased risk of adverse outcomes, both as an indicator of underlying comorbidities and as a determinant independent of baseline risk.
Translational Outlook: Future studies should investigate whether aggressive medical treatment of systolic hypertension improves outcomes in patients with acute aortic dissection in the context of whether or not they undergo endovascular or surgical repair. 
